RxDoctor Payments Data

Michelle Miller, APRN

Adult Health · Quincy, MINPI 1932284973

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $14,400 of the $23,780 with a category attached, or 60.6%. Boston Scientific accounts for 71.5% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $18,062, more than ten times the $315 reported in 2021. Among adult health clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,780in general payments, 2019–2025

Across 307 payments — averaging $77.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$17K
  • Edwards Lifesciences$4K
  • Abbott$3K
  • Johnson & Johnson$105
  • Novartis$103
  • Cumberland Pharmaceuticals, Inc.$57
  • plus $294 from 9 others

What the payments were for

  • Speaking & faculty fees$14,40061%
  • Travel & lodging$4,25318%
  • Food & beverage$5,12722%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,780 in reported general payments places this provider in the 95th percentile of 527 adult health providers in Michigan.

See all adult health providers in Michigan

Medicare billing

Part B allowed, 2024
$18,347
Medicare patients
207
Services billed
324

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban119$114,404
XareltoRivaroxaban76$102,994
JardianceEmpagliflozin77$94,372
EntrestoSacubitril/Valsartan50$65,967
Repatha SureclickEvolocumab32$40,847
ClopidogrelClopidogrel Bisulfate455$7,977
Ranolazine ErRanolazine36$5,428
Metoprolol Succinate243$4,722
Diltiazem 24hr Er (Cd)Diltiazem Hcl69$3,580
Atorvastatin Calcium187$3,387
Prasugrel Hcl19$2,140
Rosuvastatin Calcium87$2,031
Bumetanide56$1,756
Isosorbide Mononitrate ErIsosorbide Mononitrate97$1,742
Losartan Potassium126$1,397

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$105$102,99476 claims
NovartisEntresto$103$65,96750 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 527 adult health providers in Michigan.

Other adult health in Quincy

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →